Pricing Log in Create free account

BridgeBio Pharma, Inc. (BBIO) vs BioNTech SE Sponsored ADR (BNTX)

BridgeBio Pharma, Inc. and BioNTech SE Sponsored ADR are both Biotechnology companies. BioNTech SE Sponsored ADR is the larger, with a market value of $21.6B against $14.5B — 1.5× the size. BridgeBio Pharma, Inc. grew revenue faster over the last twelve months: 167.3% against −22.7%. BridgeBio Pharma, Inc. has the higher net margin (−62.6% vs −63.8%) and the higher return on invested capital (0.00% vs −34.3%). Across the 17 metrics below, BridgeBio Pharma, Inc. leads on 11 and BioNTech SE Sponsored ADR on 6.

Valuation

Metric BBIO BNTX Biotechnology median
P/E n/m n/m 10.26
P/S 15.49 7.88 9.18
P/B n/m 1.05 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 15.90 1.84 8.98
Earnings yield (4.07%) (7.93%) (34.89%)
Free cash flow yield (2.58%) (2.44%) (24.52%)

Profitability

Metric BBIO BNTX Biotechnology median
Gross margin 94.34% 74.59% 65.16%
Operating margin (38.52%) (78.99%) 0.00%
Net margin (62.62%) (63.77%) 0.00%
Free cash flow margin (39.11%) (19.21%) 0.00%
Return on equity 26.22% (8.29%) (50.12%)
Return on assets (37.48%) (7.22%) (45.60%)
Return on invested capital 0.00% (34.28%) 0.00%

Growth

Metric BBIO BNTX Biotechnology median
Revenue growth (TTM) 167.27% (22.73%) 6.26%
EPS growth (last fiscal year) (31.25%) (77.33%) 29.88%
Revenue growth, 5-year CAGR 127.44% 42.58% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBIO BNTX Biotechnology median
Debt to equity (1.17) 0.02 0.00
Current ratio 2.09 8.55 4.89
Net debt to EBITDA (2.47) 14.29 1.01

Dividend

Metric BBIO BNTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBIO BNTX Biotechnology median
Market cap 14.47b 21.57b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack